Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, May 19, 2022

Stroke Rehabilitation is predicted to reach a market value of US$ 679.6 Mn by 2031

 If we had anything approaching decent stroke leadership we would have 100% recovery protocols by 2031. But that won't occur because existing failed stroke leadership refuses to acknowledge their complete fucking failure and step down and let survivors run it.

Stroke Rehabilitation is predicted to reach a market value of US$ 679.6 Mn by 2031

05-18-2022 08:47 PM CET | Health & Medicine

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Stroke Rehabilitation Market 2022

Stroke Rehabilitation Market 2022

Stroke Rehabilitation Market 2022

The global Stroke Rehabilitation Market is expected to witness a CAGR of 9.0% and reach US$ 679.6 Mn by the year 2032. With the way in which healthcare data gets accumulated these days (which could be inclusive of medical IoT solutions, DICOM files, and patient records), ultra-modern platforms like data fabrics are in the offing, so that distributed and structured data could be well-managed. This would be healthcare industry's situation in the upcoming period.

Click Here to get Free Sample Copy of This Report@https://www.persistencemarketresearch.com/samples/33088

Researchers are exploring recovery and rehabilitation treatments, which can have a time window of days, weeks, or months after a stroke, in parallel with efforts to improve acute stroke therapy. Therapies aimed at maximizing function in brain areas that survive a stroke or compensatory techniques to increase overall function are utilized to attain this goal.  

With recorded sales of US$ 266.4 Mn in 2021, the global stroke rehabilitation market is predicted to experience high growth over the years ahead, owing to high product adoption globally. Demand for stroke rehabilitation is estimated to surge at a CAGR of 9% from 2022 to 2032.

Rehabilitation has been shown to help people recover from strokes. Repetitive, task-specific practices with performance feedback, often provided by rehabilitation specialists, improves the recovery of specific capabilities such as walking and upper-limb movements.

Majority of stroke victims survive the initial event, but they continue to live with considerable disability for years. In the United States alone, there are over 6 million stroke survivors. As a result, research into medicines that improve the quality of life of stroke patients in the chronic phase is crucial. Several studies have found that constraint-induced treatment, locomotor training, fluoxetine, and LDOPA, all offer considerable benefits in this area. Widespread adoption, on the other hand, remains elusive, and recent negative studies highlight the need for a deeper understanding of recovery/rehabilitation and its management.

In order to increase the intensity, repetitions, specificity, and feedback during the stroke rehabilitation process, the use of technological devices is essential. Some medical devices such as electrical stimulators, robotic stimulators, wireless stimulators, non-invasive stimulators, cognitive stimulators, and others can be used in the rehabilitation of post-stroke patients. Key market players are working on developing new rehabilitation devices that can help the stroke rehabilitation market grow.

MicroTransponder has developed the Vivistim Paired VNS system, a drug-free rehabilitation solution for patients associated with ischemic stroke. It received approval in August 2021.

Request For Customization@https://www.persistencemarketresearch.com/request-customization/33088

Key Takeaways from Market Study

Electrical stimulators are more widely used than robotic stimulators, wireless stimulators, non-invasive stimulators, cognitive stimulators, and others in terms of volume. The segment held 70.6% value market share in 2021.

By stroke, ischemic strokes accounted for a market share of around 85.9% in 2021.
Hospitals and rehabilitation centers are focused on the rehabilitation of post-stroke patients. These segments together held a high market share of 53.9% in 2021.

The North America stroke rehabilitation market accounted for 34.4% of the global market share in 2021. This is due to the presence of key players in this region.

"Rising number of specialists for stroke rehabilitation, high prevalence of stroke, and increasing adoption of technology-based rehabilitation will drive demand growth of stroke rehabilitation over the coming years," says an analyst of Persistence Market Research.

Market Competition

Key suppliers of rehabilitation devices are focused on strategic collaborations and acquisitions to increase their market share value. Furthermore, throughout the ongoing pandemic, persistent demand for various treatments and devices is projected to benefit top corporations.

Market expansion is being fuelled by rising demand for home care settings, high demand for early diagnosis, and rising use of precision medicine.

In April 2022, Fesia Technology Company signed a distribution agreement with Chinesport Physiotherapy Company for the products Fesia Grasp and Fesia Walk.
In April 2021, DJO global completed the acquisition of MedShape, Inc., a privately-held medical device manufacturing company.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the stroke rehabilitation market in its latest study, presenting a historical demand assessment of 2012 - 2021 and projections for 2022 - 2032.

Buy Now@https://www.persistencemarketresearch.com/checkout/33088

The research study is based on the product (electrical stimulators [tabletop, wearable], robotic stimulators, wireless stimulators, non-invasive stimulators, cognitive stimulators, and others), stroke (ischemic stroke, hemorrhagic stroke, and transient ischemic stroke), and end user (hospitals, speciality clinics, ambulatory surgical centers, long-term treatment centers, home care settings, and rehabilitation centers), across seven key regions of the world.

Persistence Market Research's Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations.

Human Insulin Market- https://www.persistencemarketresearch.com/market-research/human-insulin-market.asp

Endodontics Market - https://www.persistencemarketresearch.com/market-research/endodontics-market.asp

Media Contact:

Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

No comments:

Post a Comment